EF24, a structurally similar substance to curcumin, inhibits HIF-1α and promotes its degradation by upregulating the von Hippel–Lindau tumor suppressor, synergistically enhancing the anti-tumor effects of sorafenib and abrogating drug resistance. The gene discussed is HIF1A; the disease is neoplasm.